Can patient selection for bladder preservation be based on response to chemotherapy? Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma
  • Chemotherapy, Adjuvant
  • Cisplatin
  • Doxorubicin
  • Methotrexate
  • Patient Selection
  • Urinary Bladder Neoplasms
  • Vinblastine

abstract

  • Bladder sparing in selected patients on the basis of response to neoadjuvant chemotherapy is a feasible approach that should be confirmed in prospective, randomized trials. Selected elderly patients are candidates for this approach.

publication date

  • April 2003

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.11232

PubMed ID

  • 12655521

Additional Document Info

start page

  • 1644

end page

  • 52

volume

  • 97

number

  • 7